Turtle Cameron - Insider Non-Derivative Transactions at Spyre Therapeutics, Inc. (AGLE) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Nov 24, 2023, Turtle Cameron's relationship to Spyre Therapeutics, Inc. (AGLE) is Director,Officer (Chief Executive Officer), and currently has 746,507 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other AGLE insiders.
Data Source: SEC.
Turtle Cameron - Insider Non-Derivative Transactions at AGLE
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Nov 25, 2023 | C -- (Common Stock) | 723440 | 0 | 746507 |